IRIS is poised to revolutionize the surgical training marketplace with its collaborative augmented reality (AR) software that is device agnostic. The company's innovative platform enables surgeons to train and collaborate with each other in real time. This immersive and interactive learning experience is proven to improve surgical skills and outcomes. In addition, IRIS's non-provisional patent protects its unique technology, giving it a competitive edge in the rapidly growing AR/VR surgical training market, which had $2.7 billion in revenue in 2022. IRIS is well-positioned to capture a significant share of this lucrative market.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account